← Back to Nuqta Atlas
Editorially curated · qa-cf-omics
Cystic Fibrosis CF Omics Study
Nested omics study seeking host factors associated with resistance to SARS-CoV-2 among Gulf cystic-fibrosis patients.
01 / Project overview
What the record establishes.
- Geographic scope
- Qatar/Gulf-region nested cohort
- Project type
- disease multi-omics cohort
- Research domain
- cystic fibrosis genomics and infectious-disease resilience
- Years
- Not stated
- Lifecycle status
- active or recruiting
- Status basis
- QPHI's current disease-studies page lists the nested study and recruitment through Hamad General Hospital pulmonary and chest clinics.
- Status evidence date
- 2026-08-15
- Scale
- No public target or enrollment count identified.
02 / Organizations and population
Who and what the project connects.
- Lead organizations
- Qatar Precision Health Institute · Hamad Medical Corporation
- Partner organizations
- Not stated
- Organism / population
- People with clinically diagnosed cystic fibrosis in the Gulf region
03 / Data and access
What exists and how it can be reached.
Data types
- omics
- genetic data
- clinical cystic-fibrosis phenotypes
- SARS-CoV-2 outcomes
Data access
Controlled QPHI/HMC access.
Identifiers
No public accession or identifier is listed for this record.
04 / Evidence and provenance
Why the record is included.
Inclusion basis
Named Gulf disease multi-omics study recruiting from a national specialty service.
Editorial note
Likely nested in the Disease Genomics Database; sample scale and specific omics are not listed publicly.
Sources
- primary record source Verified 2026-08-15
Release v0.2.0